gip and glp 1 receptor agonist Potential Use of GLP-1 GIP/GLP-1 Agonists for Respiratory Disorders: Where Are We at? Dual GLP-1/GIP Agonist | Tirzepatide

Oral administration of these conjugates significantly improved glucose-lowering effects compared to native GLP-1, with DBP-GLP-1 showing superior efficacy likely attributed to enhanced intestinal absorption

Despite limited big pharma involvement, venture funding is propelling new companies, potentially reshaping the industry landscape

Addressing Metabolic Dysfunction as an Independent Cancer Risk Factor Accumulating evidence positions metabolic dysfunction characterised by insulin resistance, hepatic steatosis, dyslipidaemia, and visceral adiposity as a more powerful and proximate predictor of cancer risk than elevated body weight alone

Cognitive function either improved or remained stable